Signal transductionis the process by which a chemical or physical signal is transmitted through a cell as aseries of molecular events.Proteins responsible for detecting stimuli are generally termedreceptors,although in some cases the term sensor is used.[1]The changes elicited by ligand binding (or signal sensing) in a receptor give rise to abiochemical cascade,which is a chain of biochemical events known as asignaling pathway.

When signaling pathways interact with one another they form networks, which allow cellular responses to be coordinated, often by combinatorial signaling events.[2]At the molecular level, such responses include changes in thetranscriptionortranslationof genes, andpost-translationaland conformational changes in proteins, as well as changes in their location. These molecular events are the basic mechanisms controllingcell growth,proliferation,metabolismand many other processes.[3]In multicellular organisms, signal transduction pathways regulatecell communicationin a wide variety of ways.

Each component (or node) of a signaling pathway is classified according to the role it plays with respect to the initial stimulus.Ligandsare termedfirst messengers,while receptors are thesignal transducers,which then activateprimary effectors.Such effectors are typically proteins and are often linked tosecond messengers,which can activatesecondary effectors,and so on. Depending on the efficiency of the nodes, a signal can be amplified (a concept known as signal gain), so that one signaling molecule can generate a response involving hundreds to millions of molecules.[4]As with other signals, the transduction of biological signals is characterised by delay, noise, signal feedback and feedforward and interference, which can range from negligible to pathological.[5]With the advent ofcomputational biology,theanalysisof signaling pathways and networks has become an essential tool to understand cellular functions anddisease,including signaling rewiring mechanisms underlying responses to acquired drug resistance.[6]

Simplified representation of major signal transduction pathways in mammals.

Stimuli

edit
3D Medical animation still showing signal transduction.

The basis for signal transduction is the transformation of a certain stimulus into a biochemical signal. The nature of such stimuli can vary widely, ranging from extracellular cues, such as the presence ofEGF,to intracellular events, such as the DNA damage resulting fromreplicativetelomereattrition.[7]Traditionally, signals that reach the central nervous system are classified assenses.These are transmitted fromneuronto neuron in a process calledsynaptic transmission.Many other intercellular signal relay mechanisms exist in multicellular organisms, such as those that govern embryonic development.[8]

Ligands

edit

The majority of signal transduction pathways involve the binding of signaling molecules, known as ligands, to receptors that trigger events inside the cell. The binding of a signaling molecule with a receptor causes a change in the conformation of the receptor, known asreceptor activation.Most ligands are soluble molecules from the extracellular medium which bind tocell surface receptors.These includegrowth factors,cytokinesandneurotransmitters.Components of theextracellular matrixsuch asfibronectinandhyaluronancan also bind to such receptors (integrinsandCD44,respectively). In addition, some molecules such assteroid hormonesare lipid-soluble and thus cross the plasma membrane to reach cytoplasmic ornuclear receptors.[9]In the case ofsteroid hormone receptors,their stimulation leads to binding to thepromoter regionof steroid-responsive genes.[10]

Not all classifications of signaling molecules take into account the molecular nature of each class member. For example,odorantsbelong to a wide range of molecular classes,[11]as do neurotransmitters, which range in size from small molecules such asdopamine[12]toneuropeptidessuch asendorphins.[13]Moreover, some molecules may fit into more than one class, e.g.epinephrineis a neurotransmitter when secreted by thecentral nervous systemand a hormone when secreted by theadrenal medulla.

Some receptors such asHER2are capable ofligand-independent activationwhen overexpressed or mutated. This leads to constitutive activation of the pathway, which may or may not be overturned by compensation mechanisms. In the case of HER2, which acts as a dimerization partner of otherEGFRs,constitutive activation leads to hyperproliferation andcancer.[14]

Mechanical forces

edit

The prevalence ofbasement membranesin the tissues ofEumetazoansmeans that most cell types requireattachmentto survive. This requirement has led to the development of complex mechanotransduction pathways, allowing cells to sense the stiffness of the substratum. Such signaling is mainly orchestrated infocal adhesions,regions where theintegrin-boundactincytoskeletondetects changes and transmits them downstream throughYAP1.[15]Calcium-dependentcell adhesion moleculessuch ascadherinsandselectinscan also mediate mechanotransduction.[16]Specialised forms of mechanotransduction within the nervous system are responsible formechanosensation:hearing,touch,proprioceptionandbalance.[17]

Osmolarity

edit

Cellular and systemic control ofosmotic pressure(the difference inosmolaritybetween thecytosoland the extracellular medium) is critical for homeostasis. There are three ways in which cells can detect osmotic stimuli: as changes in macromolecular crowding, ionic strength, and changes in the properties of the plasma membrane or cytoskeleton (the latter being a form of mechanotransduction).[18]These changes are detected by proteins known as osmosensors or osmoreceptors. In humans, the best characterised osmosensors aretransient receptor potential channelspresent in theprimary ciliumof human cells.[18][19]In yeast, the HOG pathway has been extensively characterised.[20]

Temperature

edit

The sensing of temperature in cells is known as thermoception and is primarily mediated bytransient receptor potential channels.[21]Additionally, animal cells contain a conserved mechanism to prevent high temperatures from causing cellular damage, theheat-shock response.Such response is triggered when high temperatures cause the dissociation of inactiveHSF1from complexes withheat shock proteinsHsp40/Hsp70andHsp90.With help from thencRNAhsr1,HSF1 then trimerizes, becoming active and upregulating the expression of its target genes.[22]Many other thermosensory mechanisms exist in bothprokaryotesandeukaryotes.[21]

Light

edit

In mammals,lightcontrols the sense ofsightand thecircadian clockby activating light-sensitive proteins inphotoreceptor cellsin theeye'sretina.In the case of vision, light is detected byrhodopsininrodandcone cells.[23]In the case of the circadian clock, a differentphotopigment,melanopsin,is responsible for detecting light inintrinsically photosensitive retinal ganglion cells.[24]

Receptors

edit

Receptors can be roughly divided into two major classes:intracellularandextracellularreceptors.

Extracellular receptors

edit

Extracellular receptors areintegral transmembrane proteinsand make up most receptors. They span theplasma membraneof the cell, with one part of the receptor on the outside of the cell and the other on the inside. Signal transduction occurs as a result of a ligand binding to the outside region of the receptor (the ligand does not pass through the membrane). Ligand-receptor binding induces a change in theconformationof the inside part of the receptor, a process sometimes called "receptor activation".[25]This results in either the activation of an enzyme domain of the receptor or the exposure of a binding site for other intracellular signaling proteins within the cell, eventually propagating the signal through the cytoplasm.

Ineukaryoticcells, most intracellular proteins activated by a ligand/receptor interaction possess an enzymatic activity; examples includetyrosine kinaseandphosphatases.Often such enzymes are covalently linked to the receptor. Some of them createsecond messengerssuch ascyclic AMPandIP3,the latter controlling the release of intracellular calcium stores into the cytoplasm. Other activated proteins interact withadaptor proteinsthat facilitate signaling protein interactions and coordination of signaling complexes necessary to respond to a particular stimulus. Enzymes and adaptor proteins are both responsive to various second messenger molecules.

Many adaptor proteins and enzymes activated as part of signal transduction possess specializedprotein domainsthat bind to specific secondary messenger molecules. For example, calcium ions bind to theEF handdomains ofcalmodulin,allowing it to bind and activatecalmodulin-dependent kinase.PIP3and other phosphoinositides do the same thing to thePleckstrin homology domainsof proteins such as the kinase proteinAKT.

G protein–coupled receptors

edit

G protein–coupled receptors (GPCRs) are a family of integral transmembrane proteins that possess seven transmembrane domains and are linked to a heterotrimericG protein.With nearly 800 members, this is the largest family of membrane proteins and receptors in mammals. Counting all animal species, they add up to over 5000.[26]Mammalian GPCRs are classified into 5 major families:rhodopsin-like,secretin-like,metabotropic glutamate,adhesionandfrizzled/smoothened,with a few GPCR groups being difficult to classify due to low sequence similarity, e.g.vomeronasal receptors.[26]Other classes exist in eukaryotes, such as theDictyosteliumcyclic AMP receptorsandfungal mating pheromone receptors.[26]

Signal transduction by a GPCR begins with an inactive G protein coupled to the receptor; the G protein exists as a heterotrimer consisting of Gα, Gβ, and Gγ subunits.[27]Once the GPCR recognizes a ligand, the conformation of the receptor changes to activate the G protein, causing Gα to bind a molecule of GTP and dissociate from the other two G-protein subunits. The dissociation exposes sites on the subunits that can interact with other molecules.[28]The activated G protein subunits detach from the receptor and initiate signaling from many downstream effector proteins such asphospholipasesandion channels,the latter permitting the release of second messenger molecules.[29]The total strength of signal amplification by a GPCR is determined by the lifetimes of the ligand-receptor complex and receptor-effector protein complex and the deactivation time of the activated receptor and effectors through intrinsic enzymatic activity; e.g. via protein kinase phosphorylation or b-arrestin-dependent internalization.

A study was conducted where apoint mutationwas inserted into the gene encoding thechemokinereceptor CXCR2; mutated cells underwent amalignant transformationdue to theexpressionof CXCR2 in an active conformation despite the absence of chemokine-binding. This meant that chemokine receptors can contribute to cancer development.[30]

Tyrosine, Ser/Thr and Histidine-specific protein kinases

edit

Receptor tyrosine kinases(RTKs) are transmembrane proteins with an intracellularkinasedomain and an extracellular domain that bindsligands;examples includegrowth factorreceptors such as theinsulin receptor.[31]To perform signal transduction, RTKs need to formdimersin theplasma membrane;[32]the dimer is stabilized by ligands binding to the receptor. The interaction between the cytoplasmic domains stimulates the autophosphorylationoftyrosineresidues within the intracellular kinase domains of the RTKs, causing conformational changes. Subsequent to this, the receptors' kinase domains are activated, initiatingphosphorylationsignaling cascades of downstream cytoplasmic molecules that facilitate various cellular processes such ascell differentiationandmetabolism.[31]Many Ser/Thr and dual-specificityprotein kinasesare important for signal transduction, either acting downstream of [receptor tyrosine kinases], or as membrane-embedded or cell-soluble versions in their own right. The process of signal transduction involves around 560 knownprotein kinasesandpseudokinases,encoded by the humankinome[33][34]

As is the case with GPCRs, proteins that bind GTP play a major role in signal transduction from the activated RTK into the cell. In this case, the G proteins are members of theRas,Rho,and Raf families, referred to collectively assmall G proteins.They act as molecular switches usually tethered to membranes byisoprenylgroups linked to their carboxyl ends. Upon activation, they assign proteins to specific membrane subdomains where they participate in signaling. Activated RTKs in turn activate small G proteins that activateguanine nucleotide exchange factorssuch asSOS1.Once activated, these exchange factors can activate more small G proteins, thus amplifying the receptor's initial signal. The mutation of certain RTK genes, as with that of GPCRs, can result in theexpressionof receptors that exist in a constitutively activated state; such mutated genes may act asoncogenes.[35]

Histidine-specific protein kinasesare structurally distinct from other protein kinases and are found in prokaryotes, fungi, and plants as part of a two-component signal transduction mechanism: a phosphate group from ATP is first added to a histidine residue within the kinase, then transferred to an aspartate residue on a receiver domain on a different protein or the kinase itself, thus activating the aspartate residue.[36]

Integrins

edit
An overview of integrin-mediated signal transduction, adapted from Hehlgenset al.(2007).[37]

Integrins are produced by a wide variety of cells; they play a role in cell attachment to other cells and theextracellular matrixand in the transduction of signals from extracellular matrix components such asfibronectinandcollagen.Ligand binding to the extracellular domain of integrins changes the protein's conformation, clustering it at the cell membrane to initiate signal transduction. Integrins lack kinase activity; hence, integrin-mediated signal transduction is achieved through a variety of intracellular protein kinases and adaptor molecules, the main coordinator beingintegrin-linked kinase.[37]As shown in the adjacent picture, cooperative integrin-RTK signaling determines the timing of cellular survival,apoptosis,proliferation,anddifferentiation.

Important differences exist between integrin-signaling in circulating blood cells and non-circulating cells such asepithelial cells;integrins of circulating cells are normally inactive. For example, cell membrane integrins on circulatingleukocytesare maintained in an inactive state to avoid epithelial cell attachment; they are activated only in response to stimuli such as those received at the site of aninflammatory response.In a similar manner, integrins at the cell membrane of circulatingplateletsare normally kept inactive to avoidthrombosis.Epithelial cells (which are non-circulating) normally have active integrins at their cell membrane, helping maintain their stable adhesion to underlying stromal cells that provide signals to maintain normal functioning.[38]

In plants, there are no bona fide integrin receptors identified to date; nevertheless, several integrin-like proteins were proposed based on structural homology with the metazoan receptors.[39]Plants contain integrin-linked kinases that are very similar in their primary structure with the animal ILKs. In the experimental model plantArabidopsis thaliana,one of the integrin-linked kinase genes,ILK1,has been shown to be a critical element in the plant immune response to signal molecules from bacterial pathogens and plant sensitivity to salt and osmotic stress.[40]ILK1 protein interacts with the high-affinity potassium transporterHAK5and with the calcium sensor CML9.[40][41]

Toll-like receptors

edit

When activated, toll-like receptors (TLRs) take adapter molecules within the cytoplasm of cells in order to propagate a signal. Four adaptor molecules are known to be involved in signaling, which areMyd88,TIRAP,TRIF,andTRAM.[42][43][44]These adapters activate other intracellular molecules such asIRAK1,IRAK4,TBK1,andIKKithat amplify the signal, eventually leading to theinductionor suppression of genes that cause certain responses. Thousands of genes are activated by TLR signaling, implying that this method constitutes an important gateway for gene modulation.

Ligand-gated ion channels

edit

A ligand-gated ion channel, upon binding with a ligand, changes conformation to open a channel in the cell membrane through which ions relaying signals can pass. An example of this mechanism is found in the receiving cell of a neuralsynapse.The influx of ions that occurs in response to the opening of these channels inducesaction potentials,such as those that travel along nerves, by depolarizing the membrane of post-synaptic cells, resulting in the opening of voltage-gated ion channels.

An example of an ion allowed into the cell during a ligand-gated ion channel opening is Ca2+;it acts as a second messenger initiating signal transduction cascades and altering the physiology of the responding cell. This results in amplification of the synapse response between synaptic cells by remodelling thedendritic spinesinvolved in the synapse.

Intracellular receptors

edit

Intracellular receptors, such asnuclear receptorsandcytoplasmic receptors,are soluble proteins localized within their respective areas. The typical ligands for nuclear receptors are non-polar hormones like thesteroidhormonestestosteroneandprogesteroneand derivatives of vitamins A and D. To initiate signal transduction, the ligand must pass through the plasma membrane by passive diffusion. On binding with the receptor, the ligands pass through thenuclear membraneinto thenucleus,altering gene expression.

Activated nuclear receptors attach to the DNA at receptor-specifichormone-responsive element(HRE) sequences, located in thepromoterregion of the genes activated by the hormone-receptor complex. Due to their enabling gene transcription, they are alternatively called inductors ofgene expression.All hormones that act by regulation of gene expression have two consequences in their mechanism of action; their effects are produced after a characteristically long period of time and their effects persist for another long period of time, even after their concentration has been reduced to zero, due to a relatively slow turnover of most enzymes and proteins that would either deactivate or terminate ligand binding onto the receptor.

Nucleic receptors have DNA-binding domains containingzinc fingersand a ligand-binding domain; the zinc fingers stabilize DNA binding by holding its phosphate backbone. DNA sequences that match the receptor are usually hexameric repeats of any kind; the sequences are similar but their orientation and distance differentiate them. The ligand-binding domain is additionally responsible fordimerizationof nucleic receptors prior to binding and providing structures fortransactivationused for communication with the translational apparatus.

Steroid receptorsare a subclass of nuclear receptors located primarily within the cytosol. In the absence of steroids, they associate in an aporeceptor complex containingchaperoneorheatshock proteins(HSPs). The HSPs are necessary to activate the receptor by assisting the protein tofoldin a way such that thesignal sequenceenabling its passage into the nucleus is accessible. Steroid receptors, on the other hand, may be repressive on gene expression when their transactivation domain is hidden. Receptor activity can be enhanced by phosphorylation ofserineresidues at their N-terminal as a result of another signal transduction pathway, a process calledcrosstalk.

Retinoic acid receptorsare another subset of nuclear receptors. They can be activated by an endocrine-synthesized ligand that entered the cell by diffusion, a ligand synthesised from aprecursorlikeretinolbrought to the cell through the bloodstream or a completely intracellularly synthesised ligand likeprostaglandin.These receptors are located in the nucleus and are not accompanied by HSPs. They repress their gene by binding to their specific DNA sequence when no ligand binds to them, and vice versa.

Certain intracellular receptors of the immune system are cytoplasmic receptors; recently identifiedNOD-like receptors(NLRs) reside in the cytoplasm of someeukaryoticcells and interact with ligands using aleucine-rich repeat(LRR) motif similar to TLRs. Some of these molecules likeNOD2interact withRIP2 kinasethat activatesNF-κBsignaling, whereas others likeNALP3interact with inflammatorycaspasesand initiate processing of particularcytokineslikeinterleukin-1β.[45][46]

Second messengers

edit

First messengers are the signaling molecules (hormones, neurotransmitters, and paracrine/autocrine agents) that reach the cell from the extracellular fluid and bind to their specific receptors. Second messengers are the substances that enter the cytoplasm and act within the cell to trigger a response. In essence, second messengers serve as chemical relays from the plasma membrane to the cytoplasm, thus carrying out intracellular signal transduction.

Calcium

edit

The release of calcium ions from theendoplasmic reticuluminto thecytosolresults in its binding to signaling proteins that are then activated; it is then sequestered in thesmooth endoplasmic reticulum[47]and themitochondria.Two combined receptor/ion channel proteins control the transport of calcium: theInsP3-receptorthat transports calcium upon interaction withinositol triphosphateon its cytosolic side; and theryanodine receptornamed after thealkaloidryanodine,similar to the InsP3receptor but having afeedback mechanismthat releases more calcium upon binding with it. The nature of calcium in the cytosol means that it is active for only a very short time, meaning its free state concentration is very low and is mostly bound to organelle molecules likecalreticulinwhen inactive.

Calcium is used in many processes including muscle contraction, neurotransmitter release from nerve endings, andcell migration.The three main pathways that lead to its activation are GPCR pathways, RTK pathways, and gated ion channels; it regulates proteins either directly or by binding to an enzyme.

Lipid messengers

edit

Lipophilic second messenger molecules are derived from lipids residing in cellular membranes; enzymes stimulated by activated receptors activate the lipids by modifying them. Examples includediacylglycerolandceramide,the former required for the activation ofprotein kinase C.

Nitric oxide

edit

Nitric oxide (NO) acts as a second messenger because it is afree radicalthat can diffuse through the plasma membrane and affect nearby cells. It is synthesised fromarginineand oxygen by theNO synthaseand works through activation ofsoluble guanylyl cyclase,which when activated produces another second messenger, cGMP. NO can also act through covalent modification of proteins or their metal co-factors; some have a redox mechanism and are reversible. It is toxic in high concentrations and causes damage duringstroke,but is the cause of many other functions like the relaxation of blood vessels,apoptosis,and penileerections.

Redox signaling

edit

In addition to nitric oxide, other electronically activated species are also signal-transducing agents in a process calledredox signaling.Examples includesuperoxide,hydrogen peroxide,carbon monoxide,andhydrogen sulfide.Redox signaling also includes active modulation of electronic flows insemiconductivebiological macromolecules.[48]

Cellular responses

edit

Gene activations[49]and metabolism alterations[50]are examples of cellular responses to extracellular stimulation that require signal transduction. Gene activation leads to further cellular effects, since the products of responding genes include instigators of activation; transcription factors produced as a result of a signal transduction cascade can activate even more genes. Hence, an initial stimulus can trigger the expression of a large number of genes, leading to physiological events like the increased uptake of glucose from the blood stream[50]and the migration ofneutrophilsto sites of infection. The set of genes and their activation order to certain stimuli is referred to as agenetic program.[51]

Mammalian cells require stimulation for cell division and survival; in the absence ofgrowth factor,apoptosisensues. Such requirements for extracellular stimulation are necessary for controlling cell behavior in unicellular and multicellular organisms; signal transduction pathways are perceived to be so central to biological processes that a large number of diseases are attributed to their dysregulation. Three basic signals determine cellular growth:

  • Stimulatory (growth factors)
    • Transcription dependent response
      For example, steroids act directly as transcription factor (gives slow response, as transcription factor must bind DNA, which needs to be transcribed. Produced mRNA needs to be translated, and the produced protein/peptide can undergoposttranslational modification(PTM))
    • Transcription independent response
      For example,epidermal growth factor(EGF) binds theepidermal growth factor receptor(EGFR), which causes dimerization and autophosphorylation of the EGFR, which in turn activates the intracellular signaling pathway.[52]
  • Inhibitory (cell-cell contact)
  • Permissive (cell-matrix interactions)

The combination of these signals is integrated into altered cytoplasmic machinery which leads to altered cell behaviour.

Major pathways

edit
How to read signal transduction diagrams, what does normal arrow and flathead arrow means.
Elements of Signal transduction cascade networking

Following are some major signaling pathways, demonstrating how ligands binding to their receptors can affect second messengers and eventually result in altered cellular responses.

History

edit
Occurrence of the term "signal transduction" inMEDLINE-indexed papers since 1977

The earliest notion of signal transduction can be traced back to 1855, whenClaude Bernardproposed that ductless glands such as thespleen,thethyroidandadrenal glands,were responsible for the release of "internal secretions" with physiological effects.[56]Bernard's "secretions" were later named "hormones"byErnest Starlingin 1905.[57]Together withWilliam Bayliss,Starling had discoveredsecretinin 1902.[56]Although many other hormones, most notablyinsulin,were discovered in the following years, the mechanisms remained largely unknown.

The discovery ofnerve growth factorbyRita Levi-Montalciniin 1954, andepidermal growth factorbyStanley Cohenin 1962, led to more detailed insights into the molecular basis of cell signaling, in particulargrowth factors.[58]Their work, together withEarl Wilbur Sutherland's discovery ofcyclic AMPin 1956, prompted the redefinition ofendocrine signalingto include only signaling from glands, while the termsautocrineandparacrinebegan to be used.[59]Sutherland was awarded the 1971Nobel Prize in Physiology or Medicine,while Levi-Montalcini and Cohen shared it in 1986.

In 1970,Martin Rodbellexamined the effects ofglucagonon a rat's liver cell membrane receptor. He noted thatguanosine triphosphatedisassociated glucagon from this receptor and stimulated theG-protein,which strongly influenced the cell's metabolism. Thus, he deduced that the G-protein is a transducer that accepts glucagon molecules and affects the cell.[60]For this, he shared the 1994Nobel Prize in Physiology or MedicinewithAlfred G. Gilman.Thus, the characterization of RTKs and GPCRs led to the formulation of the concept of "signal transduction", a word first used in 1972.[61]Some early articles used the termssignal transmissionandsensory transduction.[62][63]In 2007, a total of 48,377 scientific papers—including 11,211review papers—were published on the subject. The term first appeared in a paper's title in 1979.[64][65]Widespread use of the term has been traced to a 1980 review article by Rodbell:[60][66]Research papers focusing on signal transduction first appeared in large numbers in the late 1980s and early 1990s.[46]

Signal transduction inImmunology

edit

The purpose of this section is to briefly describe some developments in immunology in the 1960s and 1970s, relevant to the initial stages of transmembrane signal transduction, and how they impacted our understanding of immunology, and ultimately of other areas of cell biology.

The relevant events begin with the sequencing ofmyeloma proteinlight chains, which are found in abundance in the urine of individuals withmultiple myeloma.Biochemical experiments revealed that these so-called Bence Jones proteins consisted of 2 discrete domains –one that varied from one molecule to the next (the V domain) and one that did not (the Fc domain or theFragment crystallizable region).[67]An analysis of multiple V region sequences by Wu and Kabat[68]identified locations within the V region that were hypervariable and which, they hypothesized, combined in the folded protein to form the antigen recognition site. Thus, within a relatively short time a plausible model was developed for the molecular basis of immunological specificity, and for mediation of biological function through the Fc domain. Crystallization of an IgG molecule soon followed[69]) confirming the inferences based on sequencing, and providing an understanding of immunological specificity at the highest level of resolution.

The biological significance of these developments was encapsulated in the theory ofclonal selection[70]which holds that aB cellhas on its surface immunoglobulin receptors whose antigen-binding site is identical to that of antibodies that are secreted by the cell when it encounters an antigen, and more specifically a particular B cell clone secretes antibodies with identical sequences. The final piece of the story, theFluid mosaic modelof the plasma membrane provided all the ingredients for a new model for the initiation of signal transduction; viz, receptor dimerization.

The first hints of this were obtained by Becker et al[71]who demonstrated that the extent to which humanbasophils—for which bivalentImmunoglobulin E(IgE) functions as a surface receptor – degranulate, depends on the concentration of anti IgE antibodies to which they are exposed, and results in a redistribution of surface molecules, which is absent when monovalentligandis used. The latter observation was consistent with earlier findings by Fanger et al.[72]These observations tied a biological response to events and structural details of molecules on the cell surface. A preponderance of evidence soon developed that receptor dimerization initiates responses (reviewed in[73]) in a variety of cell types, including B cells.

Such observations led to a number of theoretical (mathematical) developments. The first of these was a simple model proposed by Bell[74]which resolved an apparent paradox: clustering forms stable networks; i.e. binding is essentially irreversible, whereas the affinities of antibodies secreted by B cells increase as the immune response progresses. A theory of the dynamics of cell surface clustering on lymphocyte membranes was developed byDeLisiand Perelson[75]who found the size distribution of clusters as a function of time, and its dependence on the affinity and valence of the ligand. Subsequent theories for basophils and mast cells were developed by Goldstein and Sobotka and their collaborators,[76][77]all aimed at the analysis of dose-response patterns of immune cells and their biological correlates.[78]For a recent review of clustering in immunological systems see.[79]

Ligand binding to cell surface receptors is also critical to motility, a phenomenon that is best understood in single-celled organisms. An example is a detection and response to concentration gradients by bacteria[80]-–the classic mathematical theory appearing in.[81]A recent account can be found in[82]

See also

edit

References

edit
  1. ^Bradshaw RA, Dennis EA, eds. (2010).Handbook of Cell Signaling(2nd ed.). Amsterdam, Netherlands: Academic Press.ISBN9780123741455.
  2. ^Papin JA, Hunter T, Palsson BO, Subramaniam S (February 2005). "Reconstruction of cellular signalling networks and analysis of their properties".Nature Reviews. Molecular Cell Biology.6(2): 99–111.doi:10.1038/nrm1570.PMID15654321.S2CID3065483.
  3. ^Krauss G (2008).Biochemistry of Signal Transduction and Regulation.Wiley-VCH. p. 15.ISBN978-3527313976.
  4. ^Reece J, Campbell N (2002).Biology.San Francisco: Benjamin Cummings.ISBN978-0-8053-6624-2.
  5. ^Kolch W, Halasz M, Granovskaya M, Kholodenko BN (September 2015). "The dynamic control of signal transduction networks in cancer cells".Nature Reviews. Cancer.15(9): 515–27.doi:10.1038/nrc3983.PMID26289315.S2CID35252401.
  6. ^Bago R, Sommer E, Castel P, Crafter C, Bailey FP, Shpiro N, Baselga J, Cross D, Eyers PA, Alessi DR (2016) The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growth. EMBO Journal 35:1902-22
  7. ^Smogorzewska A, de Lange T (August 2002)."Different telomere damage signaling pathways in human and mouse cells".The EMBO Journal.21(16): 4338–48.doi:10.1093/emboj/cdf433.PMC126171.PMID12169636.
  8. ^Lawrence PA, Levine M (April 2006)."Mosaic and regulative development: two faces of one coin".Current Biology.16(7): R236-9.doi:10.1016/j.cub.2006.03.016.PMID16581495.
  9. ^Beato M, Chávez S, Truss M (April 1996). "Transcriptional regulation by steroid hormones".Steroids.61(4): 240–51.doi:10.1016/0039-128X(96)00030-X.PMID8733009.S2CID20654561.
  10. ^Hammes SR (March 2003)."The further redefining of steroid-mediated signaling".Proceedings of the National Academy of Sciences of the United States of America.100(5): 2168–70.Bibcode:2003PNAS..100.2168H.doi:10.1073/pnas.0530224100.PMC151311.PMID12606724.
  11. ^Ronnett GV, Moon C (2002). "G proteins and olfactory signal transduction".Annual Review of Physiology.64(1): 189–222.doi:10.1146/annurev.physiol.64.082701.102219.PMID11826268.
  12. ^Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (January 1998). "Dopamine receptors: from structure to function".Physiological Reviews.78(1): 189–225.doi:10.1152/physrev.1998.78.1.189.PMID9457173.
  13. ^Goldstein A (September 1976). "Opioid peptides endorphins in pituitary and brain".Science.193(4258): 1081–6.Bibcode:1976Sci...193.1081G.doi:10.1126/science.959823.PMID959823.
  14. ^Koboldt DC, Fulton RS, McLellan MD, Schmidt H, Kalicki-Veizer J, McMichael JF, et al. (The Cancer Genome Atlas Network) (October 2012)."Comprehensive molecular portraits of human breast tumours".Nature.490(7418): 61–70.Bibcode:2012Natur.490...61T.doi:10.1038/nature11412.PMC3465532.PMID23000897.
  15. ^Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, et al. (June 2011). "Role of YAP/TAZ in mechanotransduction".Nature.474(7350): 179–83.doi:10.1038/nature10137.PMID21654799.S2CID205225137.
  16. ^Ingber DE (May 2006)."Cellular mechanotransduction: putting all the pieces together again".FASEB Journal.20(7): 811–27.doi:10.1096/fj.05-5424rev.PMID16675838.S2CID21267494.
  17. ^Kung C (August 2005). "A possible unifying principle for mechanosensation".Nature.436(7051): 647–54.Bibcode:2005Natur.436..647K.doi:10.1038/nature03896.PMID16079835.S2CID4374012.
  18. ^abPedersen SF, Kapus A, Hoffmann EK (September 2011)."Osmosensory mechanisms in cellular and systemic volume regulation".Journal of the American Society of Nephrology.22(9): 1587–97.doi:10.1681/ASN.2010121284.PMID21852585.
  19. ^Verbalis JG (December 2007)."How does the brain sense osmolality?".Journal of the American Society of Nephrology.18(12): 3056–9.doi:10.1681/ASN.2007070825.PMID18003769.
  20. ^Hohmann S (June 2002)."Osmotic stress signaling and osmoadaptation in yeasts".Microbiology and Molecular Biology Reviews.66(2): 300–72.doi:10.1128/MMBR.66.2.300-372.2002.PMC120784.PMID12040128.
  21. ^abSengupta P, Garrity P (April 2013)."Sensing temperature".Current Biology.23(8): R304-7.doi:10.1016/j.cub.2013.03.009.PMC3685181.PMID23618661.
  22. ^Shamovsky I, Ivannikov M, Kandel ES, Gershon D, Nudler E (March 2006). "RNA-mediated response to heat shock in mammalian cells".Nature.440(7083): 556–60.Bibcode:2006Natur.440..556S.doi:10.1038/nature04518.PMID16554823.S2CID4311262.
  23. ^Burns ME, Arshavsky VY (November 2005)."Beyond counting photons: trials and trends in vertebrate visual transduction".Neuron.48(3): 387–401.doi:10.1016/j.neuron.2005.10.014.PMID16269358.
  24. ^Berson DM (August 2007)."Phototransduction in ganglion-cell photoreceptors".Pflügers Archiv.454(5): 849–55.doi:10.1007/s00424-007-0242-2.PMID17351786.
  25. ^"A molecular model for receptor activation"(PDF).
  26. ^abcFredriksson R, Schiöth HB (May 2005). "The repertoire of G-protein-coupled receptors in fully sequenced genomes".Molecular Pharmacology.67(5): 1414–25.doi:10.1124/mol.104.009001.PMID15687224.S2CID7938806.
  27. ^Qin K, Dong C, Wu G, Lambert NA (August 2011)."Inactive-state preassembly of G(q)-coupled receptors and G(q) heterotrimers".Nature Chemical Biology.7(10): 740–7.doi:10.1038/nchembio.642.PMC3177959.PMID21873996.
  28. ^Berg JM, Tymoczko JL, Stryer L, Clarke ND (2002).Biochemistry.San Francisco: W.H. Freeman.ISBN978-0-7167-4954-7.
  29. ^Yang W, Xia S (2006)."Mechanisms of regulation and function of G-protein-coupled receptor kinases".World J Gastroenterol.12(48): 7753–7.doi:10.3748/wjg.v12.i48.7753.PMC4087537.PMID17203515.
  30. ^Burger M, Burger JA, Hoch RC, Oades Z, Takamori H, Schraufstatter IU (August 1999)."Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor".Journal of Immunology.163(4): 2017–22.doi:10.4049/jimmunol.163.4.2017.PMID10438939.S2CID45743458.
  31. ^abLi E, Hristova K (May 2006)."Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies".Biochemistry.45(20): 6241–51.doi:10.1021/bi060609y.PMC4301406.PMID16700535.
  32. ^Schlessinger J (November 1988). "Signal transduction by allosteric receptor oligomerization".Trends in Biochemical Sciences.13(11): 443–7.doi:10.1016/0968-0004(88)90219-8.PMID3075366.
  33. ^Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (December 2002). "The protein kinase complement of the human genome".Science.298(5600): 1912–34.Bibcode:2002Sci...298.1912M.doi:10.1126/science.1075762.PMID12471243.S2CID26554314.
  34. ^Reiterer V, Eyers PA, Farhan H (September 2014). "Day of the dead: pseudokinases and pseudophosphatases in physiology and disease".Trends in Cell Biology.24(9): 489–505.doi:10.1016/j.tcb.2014.03.008.PMID24818526.
  35. ^Roskoski R (June 2004). "The ErbB/HER receptor protein-tyrosine kinases and cancer".Biochemical and Biophysical Research Communications.319(1): 1–11.doi:10.1016/j.bbrc.2004.04.150.PMID15158434.
  36. ^Wolanin PM, Thomason PA, Stock JB (September 2002)."Histidine protein kinases: key signal transducers outside the animal kingdom".Genome Biology.3(10): REVIEWS3013.doi:10.1186/gb-2002-3-10-reviews3013.PMC244915.PMID12372152.
  37. ^abHehlgans S, Haase M, Cordes N (January 2007). "Signalling via integrins: implications for cell survival and anticancer strategies".Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.1775(1): 163–80.doi:10.1016/j.bbcan.2006.09.001.PMID17084981.
  38. ^Gilcrease MZ (March 2007). "Integrin signaling in epithelial cells".Cancer Letters.247(1): 1–25.doi:10.1016/j.canlet.2006.03.031.PMID16725254.
  39. ^Knepper C, Savory EA, Day B (May 2011)."Arabidopsis NDR1 is an integrin-like protein with a role in fluid loss and plasma membrane-cell wall adhesion".Plant Physiology.156(1): 286–300.doi:10.1104/pp.110.169656.PMC3091050.PMID21398259.
  40. ^abBrauer EK, Ahsan N, Dale R, Kato N, Coluccio AE, Piñeros MA, et al. (June 2016)."The Raf-like Kinase ILK1 and the High Affinity K+ Transporter HAK5 Are Required for Innate Immunity and Abiotic Stress Response".Plant Physiology.171(2): 1470–84.doi:10.1104/pp.16.00035.PMC4902592.PMID27208244.
  41. ^Popescu SC, Popescu GV, Bachan S, Zhang Z, Seay M, Gerstein M, et al. (March 2007)."Differential binding of calmodulin-related proteins to their targets revealed through high-density Arabidopsis protein microarrays".Proceedings of the National Academy of Sciences of the United States of America.104(11): 4730–5.Bibcode:2007PNAS..104.4730P.doi:10.1073/pnas.0611615104.PMC1838668.PMID17360592.
  42. ^Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, et al. (August 2003)."Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway".Science.301(5633): 640–3.Bibcode:2003Sci...301..640Y.doi:10.1126/science.1087262.PMID12855817.S2CID19276476.
  43. ^Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T, et al. (November 2003). "TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway".Nature Immunology.4(11): 1144–50.doi:10.1038/ni986.PMID14556004.S2CID13016860.
  44. ^Yamamoto M, Sato S, Hemmi H, Sanjo H, Uematsu S, Kaisho T, et al. (November 2002). "Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4".Nature.420(6913): 324–9.Bibcode:2002Natur.420..324Y.doi:10.1038/nature01182.PMID12447441.S2CID16163262.
  45. ^Delbridge LM, O'Riordan MX (February 2007). "Innate recognition of intracellular bacteria".Current Opinion in Immunology.19(1): 10–6.doi:10.1016/j.coi.2006.11.005.PMID17126540.
  46. ^abVander AJ, Sherman J, Luciano D (1998).Human Physiology(7th ed.). McGraw-Hill. pp. 159–60.ISBN978-0-07-067065-5.
  47. ^Wilson CH, Ali ES, Scrimgeour N, Martin AM, Hua J, Tallis GA, et al. (March 2015). "Steatosis inhibits liver cell store-operated Ca²⁺ entry and reduces ER Ca²⁺ through a protein kinase C-dependent mechanism".The Biochemical Journal.466(2): 379–90.doi:10.1042/bj20140881.PMID25422863.
  48. ^Forman HJ (November 2009). "Signal transduction and reactive species".Free Radical Biology & Medicine.47(9): 1237–8.doi:10.1016/j.freeradbiomed.2009.09.002.PMID19735727.
  49. ^Lalli E, Sassone-Corsi P (July 1994)."Signal transduction and gene regulation: the nuclear response to cAMP".The Journal of Biological Chemistry.269(26): 17359–62.doi:10.1016/S0021-9258(17)32442-0.PMID8021233.
  50. ^abRosen OM (September 1987). "After insulin binds".Science.237(4821): 1452–8.Bibcode:1987Sci...237.1452R.doi:10.1126/science.2442814.PMID2442814.
  51. ^Massagué J, Gomis RR (May 2006)."The logic of TGFbeta signaling".FEBS Letters.580(12): 2811–20.doi:10.1016/j.febslet.2006.04.033.PMID16678165.
  52. ^Sako Y, Minoghchi S, Yanagida T (March 2000). "Single-molecule imaging of EGFR signalling on the surface of living cells".Nature Cell Biology.2(3): 168–72.doi:10.1038/35004044.PMID10707088.S2CID25515586.
  53. ^Orton RJ, Sturm OE, Vyshemirsky V, Calder M, Gilbert DR, Kolch W (December 2005)."Computational modelling of the receptor-tyrosine-kinase-activated MAPK pathway".The Biochemical Journal.392(Pt 2): 249–61.doi:10.1042/BJ20050908.PMC1316260.PMID16293107.
  54. ^Vogelstein B, Kinzler KW (August 2004). "Cancer genes and the pathways they control".Nature Medicine.10(8): 789–99.doi:10.1038/nm1087.PMID15286780.S2CID205383514.
  55. ^abAlberts B, Lewis J, Raff M, Roberts K, Walter P (2002).Molecular biology of the cell(4th ed.). New York: Garland Science.ISBN978-0-8153-3218-3.
  56. ^abBradshaw & Dennis (2010) p. 1.
  57. ^Tata JR (June 2005)."One hundred years of hormones".EMBO Reports.6(6): 490–6.doi:10.1038/sj.embor.7400444.PMC1369102.PMID15940278.
  58. ^Cowan WM (March 2001). "Viktor Hamburger and Rita Levi-Montalcini: the path to the discovery of nerve growth factor".Annual Review of Neuroscience.24(1): 551–600.doi:10.1146/annurev.neuro.24.1.551.PMID11283321.S2CID6747529.
  59. ^Bradshaw & Dennis (2010) p. 2.
  60. ^abRodbell M (March 1980). "The role of hormone receptors and GTP-regulatory proteins in membrane transduction".Nature.284(5751): 17–22.Bibcode:1980Natur.284...17R.doi:10.1038/284017a0.PMID6101906.S2CID5650340.
  61. ^Rensing L (1972). "Periodic geophysical and biological signals as Zeitgeber and exogenous inducers in animal organisms".International Journal of Biometeorology.16 Suppl: 113–25.PMID4621276.
  62. ^Tonndorf J (September 1975). "Davis-1961 revisited. Signal transmission in the cochlear hair cell-nerve junction".Archives of Otolaryngology.101(9): 528–35.doi:10.1001/archotol.1975.00780380006002.PMID169771.
  63. ^Ashcroft SJ, Crossley JR, Crossley PC (March 1976)."The effect of N-acylglucosamines on the biosynthesis and secretion of insulin in the rat".The Biochemical Journal.154(3): 701–7.doi:10.1042/bj1540701.PMC1172772.PMID782447.
  64. ^Hildebrand E (April 1977). "What does Halobacterium tell us about photoreception?".Biophysics of Structure and Mechanism.3(1): 69–77.doi:10.1007/BF00536457.PMID857951.S2CID62775788.
  65. ^Kenny JJ, Martínez-Maza O, Fehniger T, Ashman RF (April 1979)."Lipid synthesis: an indicator of antigen-induced signal transduction in antigen-binding cells".Journal of Immunology.122(4): 1278–84.doi:10.4049/jimmunol.122.4.1278.PMID376714.S2CID29355685.
  66. ^Gomperts BD, Kramer IM, Tatham PE (2002).Signal transduction.Academic Press.ISBN978-0-12-289631-6.
  67. ^Steiner, L A (1996) Immunoglobulin evolution, 30 years on. Glycobiology 6, 649-656
  68. ^Wu, T T, Kabat, E A (1970) An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J. Exp. Med. 132: 211-250
  69. ^Sarma, V R, Silverton, E W, Davies, D R, Terry W D (1971) The three-dimensional structure at 6 A resolution of a human gamma G1 immunoglobulin molecule, J Biol. Chem. 246 (11) 3752- 9
  70. ^Burnet, F M (1976) A modification of Jerne's theory of antibody production using the concept of clonal selection. CA: A Cancer Journal for Clinicians 26 (2) 119–21
  71. ^Becker, K E, Ishizaka, T, Metzger, H, Ishizaka, K and Grimley, P M (1973) Surface IgE on Human Basophils during histamine release. J Exp med, 138, 394-408
  72. ^Fanger, M W, Hart, D A, Wells, J V, and Nisonoff, A J (1970) Requirement for cross-linkage in the stimulation of transformation of rabbit peripheral lymphocytes by antiglobulin reagents J. Immun., 105, 1484 - 92
  73. ^Klemm J D, Schreiber S L, Crabtree G R (1998) Ann. Rev. Immunol. Dimerization as a regulatory mechanism in signal transduction 16: 569-592
  74. ^Bell, G I (1974) Model for the binding of multivalent antigens to cells, Nature Lond. 248, 430
  75. ^DeLisi, C and Perelson A (1976). The kinetics of aggregation phenomena, J. theor. Biol. 62, 159-210
  76. ^Dembo, M and Goldstein, B (1978) Theory of equilibrium binding of symmetric bivalent haptens to cell surface antibody: application to histamine release from basophils. The Journal of Immunology 121 (1), 345-353
  77. ^Sobotka, A.K. Dembo, M, Goldstein, B and Lichtenstein, L M, (1979) Antigen-specific desensitization of human basophils The Journal of Immunology, 122 (2) 511-517
  78. ^Kagey-Sobotka, A, Dembo, M, Goldstein, B, Metzger, H and Lichtenstein, L M (1981) Qualitative characteristics of histamine release from human basophils by covalently cross-linked IgE. The Journal of Immunology 127 (6), 2285-2291
  79. ^How does T cell receptor clustering impact signal transduction? Jesse Goyette, Daniel J. Nieves, Yuanqing Ma, Katharina Gaus Journal of Cell Science 2019 132:jcs226423doi:10.1242/jcs.226423Published 11 February 2019
  80. ^MacNab, R., and D. E. Koshland, Jr. (1972). The gradient-sensing mechanism in bacterial chemotaxis. Proc. Natl. Acad. Sci. U.S.A. 69:2509-2512
  81. ^Berg, H C and Purcell, E M (1977) Physics of chemoreception, Biophys. J 20(2):193-219
  82. ^Kirsten Jung, Florian Fabiani, Elisabeth Hoyer, and Jürgen Lassak 2018 Bacterial transmembrane signaling systems and their engineering for biosensing Open Biol. Apr; 8(4): 180023
edit